Psoriasis Clinical Trial
A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis
Summary
The purpose of this study is to understand the comparative effectiveness of deucravacitinib versus apremilast in adults with plaque psoriasis.
Eligibility Criteria
Inclusion Criteria:
Have been diagnosed with plaque psoriasis by a dermatologist
Newly initiating an eligible medication for enrollment (i.e., deucravacitinib, apremilast)
Actively enrolled in the CorEvitas Psoriasis Registry and have documented consent to allow copies of information from the registry be used for research purposes
Exclusion Criteria:
Currently participating in an interventional clinical trial (does not include observational registry or study)
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Waltham Massachusetts, 02451, United States
How clear is this clinincal trial information?